Clarity Pharmaceuticals Advances Prostate Cancer Trial Following Safety Review; Shares Hit New 52-Week High
Clarity Pharmaceuticals Advances Prostate Cancer Trial Following Safety Review; Shares Hit New 52-Week High
Clarity製藥在安全評估後推進前列腺癌試驗；股價創下52周新高。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間